2020
DOI: 10.1007/s00391-020-01758-7
|View full text |Cite|
|
Sign up to set email alerts
|

Hyponatriämie im Alter (II) – eine klare Therapie

Abstract: Online teilnehmen unter: www.springermedizin.de/cme Für diese Fortbildungseinheit werden 3 Punkte vergeben.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 27 publications
(23 reference statements)
0
0
0
Order By: Relevance
“…Considering the latest information about demyelinating defects and some remyelinating potentials illustrated here one still remain to know whether with delayed time after ODS damages, a sort of modus vivendi between astrocytes, oligodendrocytes, and neurons signals in making remyelination to return ODS thalamus or other CNS-damaged regions completely able to retrieve standard structures and functions. Possibly, similar repairs occurred in human ODS where most patients appeared to have a favorable clinical prognosis in the short-term post-hospitalization even though, retrospectively, there were and are still concerns for a range of 10 to 25% fatal outcomes [22,28,45,[107][108][109][110][111][112][113][114][115][116][117][118][119][120]123,259,260], or other neurologic defects [112,261], especially due other underlying disease states [45,[259][260][261][262].…”
Section: The Ais and Arl13b Label Marker Significancementioning
confidence: 99%
“…Considering the latest information about demyelinating defects and some remyelinating potentials illustrated here one still remain to know whether with delayed time after ODS damages, a sort of modus vivendi between astrocytes, oligodendrocytes, and neurons signals in making remyelination to return ODS thalamus or other CNS-damaged regions completely able to retrieve standard structures and functions. Possibly, similar repairs occurred in human ODS where most patients appeared to have a favorable clinical prognosis in the short-term post-hospitalization even though, retrospectively, there were and are still concerns for a range of 10 to 25% fatal outcomes [22,28,45,[107][108][109][110][111][112][113][114][115][116][117][118][119][120]123,259,260], or other neurologic defects [112,261], especially due other underlying disease states [45,[259][260][261][262].…”
Section: The Ais and Arl13b Label Marker Significancementioning
confidence: 99%